Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Twenty Years Of Antiretroviral Therapy For People Living With HIV: Global Costs, Health Achievements, Economic Benefits.

Forsythe SS, McGreevey W, Whiteside A, Shah M, Cohen J, Hecht R, Bollinger LA, Kinghorn A.

Health Aff (Millwood). 2019 Jul;38(7):1163-1172. doi: 10.1377/hlthaff.2018.05391.

PMID:
31260344
2.

A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs.

Hiebert L, Hecht R, Soe-Lin S, Mohamed R, Shabaruddin FH, Syed Mansor SM, Dahlui M, Azzeri A, McDonald SA.

Value Health Reg Issues. 2019 May;18:112-120. doi: 10.1016/j.vhri.2018.12.005. Epub 2019 Mar 25.

PMID:
30921591
3.

The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up.

Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S.

Health Policy Plan. 2018 May 1;33(4):528-538. doi: 10.1093/heapol/czy018.

4.

Transitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research.

Resch S, Hecht R.

J Glob Health. 2018 Jun;8(1):010301. doi: 10.7189/jogh.08.010301. Review. No abstract available.

5.

Reaching the global target to reduce stunting: an investment framework.

Shekar M, Kakietek J, D'Alimonte MR, Rogers HE, Eberwein JD, Akuoku JK, Pereira A, Soe-Lin S, Hecht R.

Health Policy Plan. 2017 Jun 1;32(5):657-668. doi: 10.1093/heapol/czw184.

6.

PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.

Cremin I, McKinnon L, Kimani J, Cherutich P, Gakii G, Muriuki F, Kripke K, Hecht R, Kiragu M, Smith J, Hinsley W, Gelmon L, Hallett TB.

Lancet HIV. 2017 May;4(5):e214-e222. doi: 10.1016/S2352-3018(17)30021-8. Epub 2017 Feb 21.

PMID:
28233660
7.

Defeating AIDS--advancing global health.

Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M; UNAIDS–Lancet Commission.

Lancet. 2015 Jul 11;386(9989):171-218. doi: 10.1016/S0140-6736(15)60658-4. Epub 2015 Jun 24. Review. No abstract available. Erratum in: Lancet. 2015 Jul 11;386(9989):136.

PMID:
26117719
8.

Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries.

Resch S, Ryckman T, Hecht R.

Lancet Glob Health. 2015 Jan;3(1):e52-61. doi: 10.1016/S2214-109X(14)70342-0.

9.

Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries.

Saxenian H, Hecht R, Kaddar M, Schmitt S, Ryckman T, Cornejo S.

Health Policy Plan. 2015 Mar;30(2):197-205. doi: 10.1093/heapol/czu003. Epub 2014 Feb 8.

10.

Induction of labor at 41 weeks of pregnancy among primiparas with an unfavorable Bishop score.

Marroquin GA, Tudorica N, Salafia CM, Hecht R, Mikhail M.

Arch Gynecol Obstet. 2013 Nov;288(5):989-93. doi: 10.1007/s00404-013-3006-6. Epub 2013 Aug 24.

PMID:
23974279
11.

Maternal body mass index does not affect neonatal umbilical artery blood gas parameters.

Chalouhi SE, Salafia C, Mikhail M, Hecht R.

J Pregnancy. 2013;2013:654817. doi: 10.1155/2013/654817. Epub 2013 Feb 21.

12.

Financing vaccinations - the South African experience.

Blecher MS, Meheus F, Kollipara A, Hecht R, Cameron NA, Pillay Y, Hanna L.

Vaccine. 2012 Sep 7;30 Suppl 3:C79-86. doi: 10.1016/j.vaccine.2012.04.042. Review.

PMID:
22939027
13.

Transparent pricing of vaccines would help poor as well as rich countries.

Hecht R, Kaddar M, Schmitt S.

BMJ. 2011 Nov 23;343:d7414. doi: 10.1136/bmj.d7414. No abstract available.

PMID:
22113835
14.

Economic returns to investment in AIDS treatment in low and middle income countries.

Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R.

PLoS One. 2011;6(10):e25310. doi: 10.1371/journal.pone.0025310. Epub 2011 Oct 5.

15.

An analysis of how the GAVI alliance and low- and middle-income countries can share costs of new vaccines.

Saxenian H, Cornejo S, Thorien K, Hecht R, Schwalbe N.

Health Aff (Millwood). 2011 Jun;30(6):1122-33. doi: 10.1377/hlthaff.2011.0332.

PMID:
21653966
16.

Millennium Development Goals for Health: What Will It Take to Accelerate Progress?.

Wagstaff A, Claeson M, Hecht RM, Gottret P, Fang Q.

In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 9.

17.

Recent Trends and Innovations in Development Assistance for Health.

Hecht R, Shah R.

In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 13.

18.

Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31.

Hecht R, Stover J, Bollinger L, Muhib F, Case K, de Ferranti D.

Lancet. 2010 Oct 9;376(9748):1254-60. doi: 10.1016/S0140-6736(10)61255-X. Review.

PMID:
20934597
19.

Critical choices in financing the response to the global HIV/AIDS pandemic.

Hecht R, Bollinger L, Stover J, McGreevey W, Muhib F, Madavo CE, de Ferranti D.

Health Aff (Millwood). 2009 Nov-Dec;28(6):1591-605. doi: 10.1377/hlthaff.28.6.1591. Erratum in: Health Aff (Millwood). 2010 Jan-Feb;29(1):223.

PMID:
19887401
20.

Improving health r&d financing for developing countries: a menu of innovative policy options.

Hecht R, Wilson P, Palriwala A.

Health Aff (Millwood). 2009 Jul-Aug;28(4):974-85. doi: 10.1377/hlthaff.28.4.974.

PMID:
19597195

Supplemental Content

Loading ...
Support Center